This company has been marked as potentially delisted and may not be actively trading. bluebird bio (BLUE) Earnings Date, Estimates & Call Transcripts Add Compare Share Share Earnings Stock AnalysisAnalyst ForecastsEarningsFDA EventsHeadlinesInsider TradesOwnershipShort InterestTrendsBuy This Stock bluebird bio Earnings Summary bluebird bio announced Q2 2024 earnings on September 27, 2024, reporting an EPS of -$8.40, which missed analysts' consensus estimates of -$8.00 by $0.40. Quarterly revenue was reported to be $16.10 million, above analyst estimates of $16.09 million. With a trailing EPS of -$41.32, bluebird bio's earnings are expected to grow next year, from ($27.25) to ($11.52) per share. Q2 2024 Earnings ResourcesQ2 2024 Earnings ReportBLUE Upcoming Earningsbluebird bio's Q1 2025 earnings is scheduled for Tuesday, August 12, 2025, with a conference call scheduled on Wednesday, August 13, 2025 at 9:30 AM ET. Check back for transcripts, audio, and key financial metrics as they become available.Upcoming Q3 Earnings DateAug. 12Before Market OpensEstimatedConsensus EPS (Sep. 27) -$8.00 Actual EPS (Sep. 27) -$8.40 Missed By -$0.40 Actual Revenue (Sep. 27) $16.10M Get bluebird bio Earnings Alerts Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on bluebird bio and other key companies, straight to your inbox. Enter your email to sign up for newsletter Sign Up Skip Charts & View Estimated and Actual Earnings DataBLUE Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.BLUE Estimated and Actual Revenue by QuarterEstimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. bluebird bio Analyst EPS EstimatesQuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateRevenue EstimateCompany Revenue GuidanceQ1 20254-$0.38-$0.07-$0.24Q2 20254-$0.33-$0.05-$0.17Q3 20254-$0.36$0.01-$0.15Q4 20254-$0.51-$0.04-$0.23 bluebird bio Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years 10 Years Time Frame Start Date End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails 8/12/2025(Estimated)--------9/27/2024Q2 2024-$8.00-$8.40 -$0.40-$0.42$16.09M$16.10M9/13/2024Q1 2024--$7.20--$0.36-$18.57M11/7/2023Q3 2023-$13.80-$13.20+$0.60-$0.66$13.56M$12.40M bluebird bio Earnings - Frequently Asked Questions When is bluebird bio's earnings date? bluebird bio has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 12th, 2025 based off last year's report dates. Learn more on BLUE's earnings history. Did bluebird bio beat their earnings estimates last quarter? In the previous quarter, bluebird bio (NASDAQ:BLUE) missed the analysts' consensus estimate of ($8.00) by $0.40 with a reported earnings per share (EPS) of ($8.40). Learn more on analysts' earnings estimate vs. BLUE's actual earnings. How much revenue does bluebird bio generate each year? bluebird bio (NASDAQ:BLUE) has a recorded annual revenue of $103.95 million. How much profit does bluebird bio generate each year? bluebird bio (NASDAQ:BLUE) has a recorded net income of -$211.91 million. BLUE has generated -$41.32 earnings per share over the last four quarters. What is bluebird bio's EPS forecast for next year? bluebird bio's earnings are expected to grow from ($27.25) per share to ($11.52) per share in the next year. More Earnings Resources from MarketBeat Related Companies CytomX Therapeutics Earnings Eupraxia Pharmaceuticals Earnings Ventyx Biosciences Earnings Caribou Biosciences Earnings Cybin Earnings Organigram Global Earnings DiaMedica Therapeutics Earnings Cardiff Oncology Earnings Rapt Therapeutics Earnings Lyell Immunopharma Earnings Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Airbnb Beats Earnings, But the Growth Story Is Losing AltitudeDutch Bros Just Flipped the Script With a Massive Earnings BeatIs Eli Lilly’s 14% Post-Earnings Slide a Buy-the-Dip Opportunity?Constellation Energy’s Earnings Beat Signals a New EraRealty Income Rallies Post-Earnings Miss—Here’s What Drove ItDon't Mix the Signal for Noise in Super Micro Computer's EarningsWhy Monolithic Power's Earnings and Guidance Ignited a Rally This page (NASDAQ:BLUE) was last updated on 8/9/2025 by MarketBeat.com Staff From Our PartnersYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredCrypto Income (almost instantly)How would you like to collect a small percentage of the $4 billion changing hands daily in the crypto market? ...Awesomely, LLC | SponsoredThe Robotics Revolution has arrived … and one $7 stock could take off as a result.Something big is brewing in Washington. According to my research, an executive order from President Trump c...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding bluebird bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share bluebird bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free BLUE Stock Alerts